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Introduction: Impaction allograft with cement is a common technique used in revision hip surgeries for the last
20 years. However, its clinical results are inconsistent. Recent studies have shown that mesenchymal stem cells
(MSCs) seeded onto allograft can enhance bone formation. This in vitro study investigates whether the increase in
temperature related to the polymerisation of bone cement will affect the viability of human MSCs.
Methods: The viability of human MSCs was measured after incubating them at temperatures of 38°C, 48°C and
58°C; durations 45 seconds, 80 seconds and 150 seconds. A control group was kept at 37°C and 5% carbon dioxide
for the duration of the investigation (7 days). During the course of the study the human MSCs were analysed for
cell metabolic activity using the alamarBlue™ assay, cell viability using both Trypan Blue dye exclusion and calcein
staining under fluorescent microscopy, and necrosis and apoptosis using Annexin V and propidium iodide for flow
cytometric analysis. A one-way analysis of variance with a priori Dunnett’s test was used to indicate the differences
between the treatment groups, when analysed against the control. This identified conditions with a significant
difference in cell metabolic activity (alamarBlue™) and cell viability (Trypan Blue).
Results: Results showed that cell metabolism was not severely affected up to 48°C/150 seconds, while cells in the
58°C group died. Similar results were shown using Trypan Blue and calcein analysis for cell viability. No significant
difference in apoptosis and necrosis of the cells was observed when human MSCs treated at 48°C/150 seconds
were compared with the control group.
Conclusions: The study suggests that human MSCs seeded onto allograft can be exposed to temperatures up to
48°C for 150 seconds. Exposure to this temperature for this time period is unlikely to occur during impaction
allograft surgery when cement is used. Therefore, in many situations, the addition of human MSCs to cemented
impaction grafting may be carried out without detrimental effects to the cells. Furthermore, previous studies have
shown that this can enhance new bone formation and repair the defects in revision situations.Introduction
There is evidence to show that the incidence of revision
hip surgery is still at a high level in the population, ranging
from 16 to 51% [1-3]. Common indications are instability,
dislocation, osteolysis and aseptic loosening of the implant.
In addition, younger patients are now undergoing total hip
arthroplasty and an ageing population means that more pa-
tients now require revisions to replace the failing implants.
In revision total hip replacement, impaction allograft
with cement has been widely used for more than 20 years
for filling bone defects and achieving initial implant* Correspondence: yr410@ic.ac.uk
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reproduction in any medium, provided the orstability, with good outcomes [4,5]. However, the regen-
eration of new bone within the defect site is often incon-
sistent and long-term clinical results are uncertain [6-9].
Ornstein and colleagues in 2006 carried out a 5-year
follow-up of socket movement and loosening after revi-
sion with impacted morselised allograft bone and ce-
ment; of 17 first-time socket revisions, they reported
that ‘five sockets showed signs of radiographic loosening
at 5 years postoperatively’ [10].
Previous studies show that human mesenchymal stem
cells (hMSCs), most commonly derived from bone mar-
row, can be proliferated and differentiated into bone
lineage using tissue engineering techniques [11-13]. This
has raised hopes of alternative stem cell therapies for the
treatment of a number of degenerative conditions [14].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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graft could restore the integrity of bone structure and
enhance new bone formation. Recently, the roles of
osteocyte and osteoblast signalling and of bone-derived
scaffolding in encouraging the osteogenic differentiation
of hMSCs have been reported [15,16]. Furthermore, in
2006 Korda and colleagues showed that these cells can
survive the impaction forces imposed by the surgeon
during impaction grafting [17]. After impacting the graft,
the surgeon usually uses acrylic bone cement to fix the
revision acetabular cup into the pelvis with the impacted
bone. During polymerisation, acrylic bone cement gener-
ates heat in an exothermic reaction that is transmitted
to the bone. hMSCs that are used in any tissue engineer-
ing application to enhance bone formation in impaction
grafting would have to withstand the temperatures gen-
erated by the polymerisation reaction.
A number of studies have measured the peak tempera-
tures at the bone–cement interface during cement poly-
merisation [18-20]. Gill and colleagues used thermal probes
that were inserted into the femoral head to record the tem-
peratures generated at the bone–cement interface during
resurfacing arthroplasty; a median maximum temperature
of 47.2°C was recorded [18]. In the literature, temperatures
between 30 and 70°C have been recorded, and the duration
of the peak temperatures varies from 30 seconds to 5 mi-
nutes. The discrepancy is mainly due to differences be-
tween in vitro studies, or those that use computer models,
and in vivo studies; it seems that computer models often
overestimate the rise in temperature of the bone to over
70°C in some cases [21]. This does not correlate with the
temperatures encountered in vivo.
The purpose of this study is to investigate in vitro the
viability of the hMSCs when they are exposed to different
temperatures and durations. For this study, we simulated
the peak temperatures previously recorded in in vivo stud-
ies when cement is used [18,20,22]. The hypothesis is that
the hMSCs can survive temperatures and durations that
occur during revision total hip replacement.
Materials and methods
Isolation of human mesenchymal stem cells
hMSCs were obtained from bone marrow cell aspirations
harvested in the iliac crest of patients during a normal total
hip replacement procedure (Royal National Orthopaedic
Hospital, Stanmore, UK). Consent was given by all patients
to obtain bone marrow during their surgery, and the con-
sent forms from the donors were signed and witnessed.
Ethical approval was gained from the NHS Health Research
Authority, National Research Ethical Committee London –
Stanmore (REC reference number 07/Q0506/10). Separate
hMSC isolations were carried out for each experiment,
from at least two different donors in total. Cells between
passages 3 and 5 were used.Cells at passage 1 were resuscitated by placing the cryovial
stored in liquid nitrogen in a water bath at 37°C. Dulbecco’s
modified Eagle’s medium (D6046; Sigma-Aldrich, Gillingham,
UK) supplemented with 20% foetal calf serum (FCS4246;
First Link, Wolverhampton, UK), penicillin (100 units/ml)
and streptomycin (100 μg/ml; Gibco, Paisley, UK) (DMEM+)
was also warmed in a water bath at 37°C. Then 1 ml
DMEM+was gently added to the cells, which were left to
stand for 5 minutes, before being transferred to a universal
tube. Doubling volumes of DMEM+were then added to
the universal tube, with 5-minute equilibration periods be-
tween each addition, until a total of 16 ml was reached. The
cell suspension was centrifuged at 2,000 rpm for 5 minutes.
The supernatant was discarded and the pellet of cells resus-
pended in 1 ml DMEM+using a gauge needle and a 1 ml
syringe. The suspension was transferred to two T225
(225 cm2 growth area) polystyrene cell culture flasks
(Corning, Tewksbury, Massachusetts, USA). Then 30 ml
DMEM+were added to each flask and designated as pas-
sage 2. The cells were incubated at 37°C and 5% carbon di-
oxide (CO2) and regularly observed under a phase-contrast
light microscope. The growth medium was changed every 3
to 5 days until the cultures reached 80 to 90% confluency.
Characterisation of human mesenchymal stem cells
hMSCs were characterised by demonstrating their multi-
potent differentiation potential for two cell lineages: adi-
pogenic and osteogenic [11].
Adipogenic differentiation
Cells at passage 3 were cultured under either adipogenic
conditions or standard conditions for 21 days in 12-well
plates (Orange Scientific, Braine l'Alleud, Belgium); 1 × 105
cells/well were plated. Adipogenic medium was DMEM+
with 1 μM dexamethasone (D2915; Sigma-Aldrich),
200 μM indomethacin (17378; Sigma-Aldrich), 500 μM 1-
methyl-3-isobutylxanthine (15879; Sigma-Aldrich) and
10 μg/ml insulin (I0516; Sigma-Aldrich). Media were chan-
ged every 3 to 5 days. After 21 days all samples were
stained with Oil Red O to check for the presence of lipids.
hMSCs were washed with phosphate-buffered saline (PBS)
and fixed in formal saline. They were covered with Oil Red
O stain for 20 minutes, rinsed with distilled water and
counterstained with Harris Haemalum for 3 minutes. Fi-
nally, they were rinsed with distilled water, air dried and ob-
served under a phase-contrast light microscope.
Osteogenic differentiation
Cells at passage 3 were cultured under either osteogenic
conditions or standard conditions for 28 days. Osteo-
genic medium was DMEM+with 0.1 μM dexametha-
sone (D2915; Sigma-Aldrich), 500 μM ascorbic acid
(A4544; Sigma-Aldrich) and 10 μM β-glycerophosphate
(G9891; Sigma-Aldrich); 5 × 104 cells were seeded per
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wells were changed every 3 to 5 days. Cell proliferation
was measured by DNA assay after 7, 14, 21 and 28 days
of culture in either DMEM+ or osteogenic medium.
Cells were washed in PBS and lysed by adding auto-
claved distilled water at 37°C. After being frozen at −70°C
and thawed three times, samples were transferred to
Eppendorf tubes and spun at 10,000 rpm for 10 minutes.
Then 100 μl supernatant were loaded in triplicate for
each sample into a FluoroNunc™ white 96-well plate.
Samples of 100 μl of the standards, ranging from 20 to
0.3125 μg/ml DNA (Sigma Aldrich, Gillingham, UK), were
also loaded in triplicate. Finally, 100 μl of 1.0 μg/ml
Hoerchst 33258 dye (Sigma-Aldrich) were added to each
sample and fluorescence was read at 460 nm using a
plate reader (Fluoroskan Ascent, Labsystems, Ramsey,
Minnesota, USA). The amount of DNA in the samples
was calculated as micrograms. DNA was expressed as
units per micrograms.
Changes in cellular morphology were regularly observed
by phase-contrast light microscopy. Mineral matrix depos-
ition by Von Kossa staining was checked at 21 days.
hMSCs were fixed in methanol. They were covered with
1.5% silver nitrate (Sigma-Aldrich) and exposed to bright
light for 1 hour. The cells were washed with distilled water
before covering with 2.5% sodium thiosulphate (BDH,
London, UK) for 5 minutes. Finally, they were counter-
stained in Neutral Red for 5 minutes, washed with distilled
water, air dried and observed by light microscopy.
Cell culture of human mesenchymal stem cells for heat
treatment
hMSCs at passage 3 were seeded into 30 wells (six-well
plates; Orange Scientific, Braine l'Alleud, Belgium) at a
density of 30,000 cells/well, with 3 ml DMEM+. The
plates were incubated at 37°C and 5% CO2 for 4 days.
Heat exposure
Table 1 presents the temperatures and corresponding
time periods that were tested in this study. The control
plate was kept in the incubator at 37°C and 5% CO2 for
the duration of the experiment (7 days).
For each experimental group, the same method of heat-
ing was used to control the temperature and duration
(Figure 1). The six-well plate was kept on a hotplate toTable 1 Conditions tested in the study, shown as
temperatures and their corresponding time periods
Temperature
Time (seconds) 38°C 48°C 58°C
45 n = 3 n = 3 n = 3
80 n = 3 n = 3 n = 3
150 n = 3 n = 3 n = 3maintain the hMSCs at 37°C. Universal tubes with 13 ml
DMEM+were heated to the required temperature in a
water bath. When this temperature was reached the
medium was immediately poured into the well containing
the hMSCs; a timer, set at 45 seconds, 80 seconds or
150 seconds, was simultaneously started. An electronic
thermometer was immersed in the medium and, if neces-
sary, a hot probe was occasionally dipped into the medium
and stirred to maintain the required temperature to an ac-
curacy of ±1°C. The peak temperatures at 10-second inter-
vals were monitored and recorded over the specified
duration, after which the medium was immediately re-
moved from the well. Then 3 ml DMEM+ at 37°C was
added to all the wells and the cells were put back into the
incubator (37°C and 5% CO2).
Analysis of cell metabolism by alamarBlue™
After heat exposure, 2 ml of a 10% dilution of alamarBlue™
solution (Alamar Biosciences, Sacramento, California,
USA) in phenol-free medium (Dulbecco’s modified Eagle’s
medium, D5921; Sigma-Aldrich) was added to the wells.
Plates were incubated at 37°C and 5% CO2 for 3 hours.
This assay was also carried out on the control plate kept
at 37°C and 5% CO2.
After 3 hours, the plates were removed from the incu-
bator. Then 100 μl alamarBlue™ solution was loaded in
triplicate into a FluoroNunc™ white 96-well plate and ab-
sorbance was measured at 590 nm on a Flouroskan As-
cent plate reader (Labsystems Inc., Ramsey, Minnesota,
USA). All samples underwent continued culture for 7 days.
After 0, 1, 2, 3 and 7 days, analysis of cell metabolic activ-
ity using alamarBlue™ assay was repeated. hMSCs were
washed with 1 ml cold PBS between alamarBlue™ analyses
and were maintained at 37°C and 5% CO2.
Scanning electron microscopy study
Table 2 summarises the groups that underwent scanning
electron microscopy (SEM) analysis (n = 2). A control
sample, kept at 37°C and 5% CO2, was also analysed.
Samples were fixed for SEM after 0 (immediately after
heating), 3 and 7 days.
The hMSCs were washed with PBS and fixed in 2.5%
glutaraldehyde with 0.1 M sodium cacodylate buffer at
pH 7.3 (Agar Scientific, Stansted, UK). They were then
washed with 0.1 M sodium cacodylate buffer at pH 7.3
(Agar Scientific) and post-fixed in 1% osmium tetroxide
(Agar Scientific) in 0.1 M sodium cacodylate buffer for
1 hour. Samples were dehydrated through a graded series of
industrial methylated spirit (20 to 60%) and ethanol (70 to
100%). Finally, samples were treated for 2 × 4 minutes with
hexamethyldisalazane (Agar Scientific) and left to dry. The
samples were then mounted on stubs and gold/palladium
sputter coated before observation under a scanning electron
microscope (JEOL JSM 5500 LV, JEOL, Tokyo, Japan).
Hot probe
Electronic thermometer
Hot DMEM+
37°C
Hot plate set at 37°C
Figure 1 Schematic illustration of the heating method used. Heated medium was added to the wells in which human mesenchymal stem
cells were cultured. The cells were kept on a hotplate at 37°C to replicate core body temperature. A hot probe was dipped into the medium to
maintain the desired temperature. The medium was removed immediately once the desired time period had elapsed. DMEM+, Dulbecco’s
modified Eagle’s medium supplemented with 20% fetal calf serum, penicillin and streptomycin.
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hMSCs were seeded into six-well plates. The same
method of heat exposure was used as before (Figure 1).
Table 3 presents the groups that were tested, with a con-
trol group kept at 37°C and 5% CO2.
The cells were trypsinised immediately after heating
(0 days) using 1 ml of 0.5% trypsin-5.3 mM ethylene-
diamine tetraacetic acid · 4Na solution (15400; Gibco).
A 1:2 dilution of the cells in Trypan Blue (T8154;
Sigma-Aldrich) was made and transferred onto a
cover-slipped haemocytometer. Using phase-contrast
light microscopy, viable cells were identified as
rounded and bright, whereas blue cells were consid-
ered nonviable. A cell count and the calculation of
percentage viability were recorded. This was repeated
after 1, 3 and 7 days.
Analysis of cell viability using calcein staining
Table 4 presents the groups that underwent Calcein
staining for cell viability 0, 1, 2 and 7 days after heating
(n = 2). hMSCs were seeded into six-well plates and onto
Thermanox™ coverslips (Nalge Nunc International,
Penfield, New York, USA). The cells were heated using
the same method as in the previous experiments
(Figure 1). After 0, 1, 2 and 7 days, the samples were
stained with 200 μl calcein and incubated for 1 hour.
Fluorescence microscopy was used to identify viable cells
(green) and necrotic cells (red).Table 2 Samples that underwent scanning electron
microscopy analysis to assess changes to cell
morphology
Temperature
Time (seconds) 38°C 48°C 58°C
45 n = 2
80 n = 2
150 n = 2Annexin V and propidium iodide labelling for apoptosis
and necrosis
hMSCs were seeded into a six-well plate at a density of
50,000 cells/well. Three wells were exposed to 48°C for
150 seconds using the same heating method as before
(Figure 1) while the other three wells were used as a control.
We followed the TACS® Annexin V Kit protocol (Trevigen
Inc., Gaithersburg, Maryland, USA) to make the Annexin V
incubation reagent, which was added to the samples 1 day
after heating. Cells were removed from the well surface
using 1 ml of 0.5% trypsin-5.3 mM ethylenediamine tetraa-
cetic acid · 4Na solution (15400; Gibco), centrifuged and re-
suspended in the incubation reagent using a 10 ml syringe
and needle. The cells were then left in the dark for 15 mi-
nutes. After adding binding buffer, the samples were proc-
essed using fluorescence-activated cell sorting flow
cytometry (Becton-Dickinson FACScan, BD Biosciences,
Franklin Lakes, New Jersey). The software used to acquire
the data was CellQuestPro™ (BD Biosciences, Franklin Lakes,
New Jersey). A dot plot was obtained for each sample, with
viable cells appearing in the lower left quadrant (no positive
staining for Annexin V or propidium iodide), early apoptotic
cells staining for Annexin V in the lower right quadrant,
necrotic cells staining for propidium iodide in the upper left
quadrant, and late apoptotic cells staining for both Annexin
V and propidium iodide in the upper right quadrant.
Statistical tests
Statistical analysis was performed using SPSS.20 soft-
ware on the results for the alamarBlue™ (Sacramento,Table 3 Samples that underwent analysis of cell viability
using the Trypan Blue exclusion dye
Temperature
Time (seconds) 48°C 58°C
45 n = 3 n = 3
80 n = 3 n = 3
150 n = 3 n = 3
Table 4 Samples that underwent calcein staining and
subsequent fluorescence microscopy to assess cell
viability
Temperature
Time (seconds) 48°C 58°C
45 n = 2 n = 2
80 n = 2 n = 2
150 n = 2 n = 2
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lingham, UK) experiments. A one-way analysis of variance
with a priori Dunnett’s test was used to indicate the differ-
ences between the treatment groups, when analysed against
the control. Significant results (P≤0.05) indicated a marked
difference in cell metabolic activity (alamarBlue™) and cell
viability (Trypan Blue).
Results
Effects of heat on cell metabolic activity
Figure 2 shows the absorbance at 590 nm of alamarBlue™
over 7 days for the 10 groups. hMSC metabolic activity
was tested 0, 1, 2, 3 and 7 days after heat treatment. A
higher absorbance corresponded to a higher metabolic ac-
tivity and is an indication of cell proliferation.
A similar pattern of cell metabolism and proliferation
can be seen for the control and cells heated to tempera-
tures up to 48°C. An increase in cell metabolic activity
occurs over time as the cell number increases. However,Temperature (°C) 
Figure 2 Comparison of hMSC metabolic activity over 7 days. The gra
temperatures and durations tested. A higher absorbance corresponds to a
number. A lag phase of cell growth is indicated between days 2 and 3 for
changes in metabolic activity over 7 days when compared to a control. hM
control kept at 37°C/5% CO2.the cells in the 58°C group showed very low proliferative
activity. Cells heated to 58°C for all time periods showed
a significant decrease (P ≤0.05) in metabolic activity
from day 1, when compared with the control.
Scanning electron microscopy analysis
The SEM analyses indicate an increase in cell density over
time for the control, 38°C and 48°C groups (Figure 3). The
same morphology was observed for these three groups;
cells displayed a flattened and elongated shape with mul-
tiple cytoplasmic processes of interaction between cells
and with the material. A decrease in cell density over time
was observed in the 58°C group, with only remnants of
the cells seen after 7 days. The cells shrunk in size, and a
disruption in cell integrity was noticed, with disrupted cell
membranes and cytoplasmic processes of interaction.
Analysis of cell viability using Trypan Blue
Trypan Blue staining showed little change in the viability
of the hMSCs in the control group and both 48°C/45 sec-
onds and 48°C/80 seconds groups over 7 days (Figure 4).
The control group showed a gradual decrease in percentage
viability over time, typical for cells in culture. All of the sam-
ples heated to 58°C showed a significant detrimental effect
on cell viability when compared with the control (P≤0.05).
The 48°C/80 seconds and 48°C/150 seconds groups
showed a noticeable fall in percentage viability at 3 days,
which was significant for the cells heated for 150 seconds
(P≤0.05). This treatment group also showed statisticaland duration (s)
ph shows the absorbance of alamarBlue™ at 590nm for the different
higher level of metabolic activity, which is an indication of cell
all samples up to 48°C/150 s, for which there were no significant
SCs heated to 58°C all eventually died. ☆P≤0.05, heated groups vs.
Figure 3 Scanning electron microscopy of human mesenchymal stem cells. A comparison of cell morphology of three different groups and
a control at (a) 0 days, (b) 3 days and (c) 7 days after heating, indicating an increase in cell density over time for the control, 38°C and 48°C
groups. Cells heated to 58°C rapidly died with signs of cell swelling and breakdown at day 3 (b), leaving cell debris by day 7 (c).
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However, both samples revealed a subsequent increase
in percentage viability between 3 and 7 days. This indi-
cates a recovery of cell number in the culture, associated
with the division of the remaining living cells. This is
seen again in Figure 5, which shows the percentage change
in the number of viable cells over 7 days; all samples ex-
cluding the 58°C group showed a net percentage increase
in the number of viable cells (values for 58°C/80 seconds
and 50°C/150 seconds were the same).
Analysis of cell viability using calcein staining and light
microscopy
A representation of the results obtained using Trypan
Blue was achieved through calcein staining. Shown in
Figure 6 are the 48°C/150 seconds and the 58°C/45 sec-
onds groups, to highlight the limit for cell survival that
lies in between these two conditions. hMSCs heated to
48°C/150 seconds display a healthy spindle morphologyand normal cell growth over 7 days with viable cells
staining fluorescent green. Heat treatment to 58°C for
45 seconds had an immediate deleterious effect on the
hMSCs, seen after 0 days with the presence of dead cells,
which stain red. After 7 days, only dead cells were seen.
Heat exposure to 48°C for 45 seconds and 80 seconds
showed similar results as for 150 seconds, with viable
cells seen staining green. Exposure to 58°C for 80 sec-
onds and 150 seconds had an immediate detrimental ef-
fect on cell viability, with red necrotic cells seen after
0 days.
Figure 7 shows images under the light microscope of
hMSCs 7 days after being subject to the same conditions
(48°C/150 seconds and 58°C/45 seconds), at magnifica-
tion × 20 (Figure 7a,c) and magnification × 40 (Figure 7b,
d). Normal spindle morphology can be seen after expos-
ure to 48°C for 150 seconds (Figure 7a,b) whereas only
cell debris is seen after exposure to 58°C for 45 seconds
(Figure 7c,d).
Figure 4 Comparison of hMSC viability over 7 days. Trypan Blue exclusion dye was used to calculate the percentage of viable cells in the
48°C and 58°C groups. The detrimental effect on cell survival after exposure to 58°C is shown. However, cell number seems to recover between 3
and 7 days after heat treatment at 48°C/80 s and 48°C/150 s. Error bars cannot be seen here for those tests in which no dead cells were seen in
any population i.e. the standard deviation = 0. ☆P≤0.05, heated groups vs. control kept at 37°C/5% CO2.
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A comparison to identify differences in cell apoptosis (using
Annexin V staining) and cell necrosis (using PI staining)
was carried out for a control group and for hMSCs heated
to 48°C/150 seconds, which was the upper limit of the cellsFigure 5 Percentage change in cell number over time for all groups.
cells (white under the microscope) in the 48°C and 58°C groups. Recovery
between the different groups; all groups excluding those heated to 58°C sthat survived heat treatment in the previous experiments.
Flow cytometry was performed 1 day after heating. This
early time point was used to pick up signs of apoptosis,
which can be induced at an early stage, and to identify any
necrotic cells that would otherwise have been lost on trans-
ferring the samples at a later stage. The graphs in Figure 8Trypan Blue exclusion dye was used to count the number of viable
of human mesenchymal stem cell viability over 7 days is shown
how net growth in cell number over the duration of the experiment.
Figure 6 Calcein staining for viable and dead cells over time using fluorescence microscopy. Comparison between the 48°C/150 seconds
and 58°C/45 seconds groups showing that the threshold for cell survival lies between these two conditions. Cells stained green are viable and
cells stained red are dead. Scale bar = 200 μm.
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lower right quadrant, suggesting there was no early apop-
tosis. In both the control and heated samples, very few cells
had positive staining for both Annexin V and PI, seen in
the upper right quadrant. This implies there were very few
late apoptotic cells. However, a small population stained for
PI in the upper left quadrant in both the control and the
heated samples, a sign of necrosis. Little difference can be
seen between the two groups, suggesting that the heat
treatment to 48°C/150 seconds had no harmful effect on
the hMSCs in terms of inducing apoptosis and necrosis,
when compared with the control.Figure 7 Light microscope images of human mesenchymal stem cells
mesenchymal stem cells in culture 7 days after heat treatment at 48°C for
morphology with cell interactions can be seen after treatment at 48°C for 1
at 58°C for 45 seconds with only cell debris remaining. The threshold for ce
Scale bar = 500 μm. (b), (d) Scale bar = 250 μm.Discussion
The use of impaction allograft with cement is a common
technique used in revision total hip replacements for
filling bone defects, and provides structural support to
implants [6,10,23]. However, the regeneration of bone
in the defect site is uncertain, with clinical results being
inconsistent [5-9]. This may be due to the necrosis of
the surrounding tissue caused by the heat generated at
the bone–cement interface and resorption of the bone
graft [18-20,24]. Previous studies have shown that
addition of hMSCs onto allograft can enhance new
bone formation [25-27].. Images taken at the end of the experiment showing the human
150 seconds (a), (b) and at 58°C for 45 seconds (c), (d). Normal spindle
50 seconds, whereas cell damage is clear 7 days after heat treatment
ll survival lies between these two conditions of heat exposure. (a), (c)
Figure 8 Cell apoptosis and cell necrosis of human mesenchymal stem cells using Annexin V and propidium iodide staining.
Comparison between the unheated (control) and heated (48°C/150 seconds) groups using flow cytometry analysis: (a) control sample stained for
Annexin V; (b) control sample stained with propidium iodide (PI) only; (c) heated sample stained for both Annexin V and PI. Annexin V staining is
indicative of cell apoptosis; PI staining is indicative of cell necrosis.
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peratures and durations that represent the highest temper-
atures generated at the bone–cement interface measured
in situ in previous studies [18-22]. However, in clinical sit-
uations when impaction allografting is performed, a large
number of hMSCs will not contact directly with the ce-
ment. Cells that are not in close proximity to the cement
interface will experience lower temperatures; this was
shown by Leeson and Lippitt in their study on the temper-
atures generated at different distances from the cement
[22]. The experimental set up we used therefore repre-
sented the worst possible conditions.
The study showed that exposure to 58°C for as short as
45 seconds caused irreversible damage to cell integrity.
This could be due to the fact that protein denaturation oc-
curs at 56°C [20,26]. However, the viability and function of
the cells were not severely affected by exposure to temper-
atures up to 48°C for 150 seconds; all six tests we used
agreed that after 7 days these cells showed signs of growth
and metabolic activity, as seen in the control sample, that
were typical of hMSCs in culture. Interestingly, all of the
samples up to this point, including the control group,
showed evidence of the lag phase of cell growth typically
between 2 and 3 days after heat treatment [17] shown by
alamarBlue™ analysis of cell metabolic activity, which gives
a proportional indication of cell number [28]. During these
days some of the cells possibly died in culture, with the
remaining cells each exhibiting a higher metabolic level,
before exponential growth in cell number after 3 days; this
hypothesis is reinforced by the Trypan Blue exclusion dye
experiment, in which the 48°C/80 seconds and 48°C/
150 seconds groups showed signs of a recovery in the cell
number in culture after 3 days. The statistical significance
in cell viability shown by Trypan Blue for the 48°C/150 sec-
onds group at 7 days indicates that the cell function ofsome hMSCs is destroyed. Further tests, however, revealed
that the remaining cells can survive and function normally
up to day 7. Light microscope images of hMSCs in culture
7 days after heat treatment to 48°C for 150 seconds
showed normal spindle cell morphology with healthy cell–
cell interactions, with the cells confirmed to be viable by
calcein staining at the same time point; the use of a fluor-
escent dye is often accepted to be more accurate in deter-
mining cell viability than Trypan Blue [29]. In this case it
would have been desirable to continue monitoring cell
growth over a longer period of time to see the full effect of
heat treatment and to witness the extent of cell survival.
In addition, heat treatment to 48°C for 150 seconds
was not shown to induce necrosis or apoptosis to any
greater extent than in the control group. Annexin V
staining for early-stage and late-stage apoptosis was neg-
ligible, the implication being that the hMSCs will not die
due to apoptosis induced by heat exposure at a later
stage postoperatively. Li and colleagues have shown that
heat shock to 48°C for 10 minutes will cause irreversible
damage to osteoblasts in vitro and induce late-stage
apoptosis [30]. This duration of heat shock at 48°C ex-
ceeds that found at the bone–cement interface and so
this damage is unlikely to occur when impaction allo-
grafting using cement is performed. Exposure of rabbit
tibia to 53°C for 1 minute causes irreversible bone in-
jury, after which healing occurs from the surrounding
tissue [31]. This temperature may occur in some cases
when cement is used, and may also affect the viability of
hMSCs since this temperature lies within our critical
temperature range of 48 to 58°C. However, heat shock
protein 70 is shown to have a protective effect in osteo-
blasts when exposed to 45°C for 10 minutes, preventing
apoptosis [30]. The protective effects of heat shock pro-
teins in mesenchymal stem cells have not yet been
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cement may activate certain proteins that could make
the cells more tolerant to higher temperatures.
Our previous study investigated the effect of the forces
generated during impaction allograft in revision total hip
replacement on the viability of hMSCs; the cells were
found to withstand these forces [17]. The current study in-
vestigated the heat generated as a single factor that may
affect the cells. In both studies the microplate alamarBlue™
assay was used to determine cell viability and proliferation,
since alamarBlue™ has been shown to have a high specifi-
city comparable with flow cytometry [32]. However, in
clinical situations, there are multiple affecting factors that
combine the impaction force, the rising temperature and
the toxicity of cement monomer. Further study should
therefore be carried out in vivo to test the combination of
all these factors that can affect the viability of the hMSCs.
In the clinical setting, heat exposure at 48°C for 150 sec-
onds covers most of the temperature conditions when
cemented impaction allograft surgeries are performed
[18,19,24]. Our results therefore suggest that the heat gen-
erated during cement polymerisation will not affect the
viability of the hMSCs, as the cells could withstand this
temperature for this duration. Furthermore, the addition
of hMSCs may enhance bone formation and repair the de-
fects in revision situations. Therefore it is important to de-
termine the ability of hMSCs to differentiate into new
bone after heat exposure both in vitro and at a later stage
in vivo [33].
Conclusions
hMSCs seeded onto allograft can be exposed to tempera-
tures up to 48°C for 150 seconds, whilst still holding onto
their cell integrity and function. This result was shown
through analysis post heat treatment for cell metabolic ac-
tivity, cell viability, cell morphological changes and cell ne-
crosis and apoptosis when compared with a control
cultured under standard conditions. Exposure of the cells
to this temperature for this time period is unlikely to occur
during impaction allograft surgery when cement is used.
The hMSCs were exposed only to temperatures found at
the bone–cement interface in clinical situations, thus pla-
cing them in the worst possible conditions. Many cells
would experience lower temperatures in real clinical situa-
tions. Therefore, in many cases the addition of hMSCs to
cemented impaction grafting may be carried out without
detrimental effects to the cells. Furthermore, previous
studies have shown that this can enhance new bone for-
mation and repair the defects in revision situations.
Abbreviations
CO2: carbon dioxide; DMEM+: Dulbecco’s modified Eagle’s medium
supplemented with 20% fetal calf serum, penicillin and streptomycin;
hMSC: human mesenchymal stem cell; PBS: phosphate-buffered saline;
SEM: scanning electron microscopy.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YR carried out the hMSC culture and heat treatment, participated in all
experiments to analyse cell function and viability, and participated in the
study design and wrote the manuscript. EG-G carried out SEM analysis and
Annexin V/PI staining for flow cytometry, contributed to the study design
and coordination, and carried out data analysis. MK aided in the study design
and helped in the cell culture protocol, in particular the acquisition of the
hMSCs. GWB participated in the study design and interpretation of data, and
helped to draft the manuscript. JH participated in the study design and data
analysis, and helped to draft the manuscript. All authors read and approved
the final manuscript.
Acknowledgements
This research project was internally funded by the John Scales Centre for
Biomedical Engineering, Institute of Orthopaedics and Musculoskeletal Science,
Division of Surgery and Interventional Science, University College London, UK.
There were no commercial organisations or funding bodies associated with
data collection and analysis, or with this study manuscript. The authors are
grateful to Dr Peter Brett at the Eastman Dental Institute, University College
London, UK for permitting the use of the flow cytometer to analyse our data.
Author details
1Imperial College School of Medicine, Imperial College London, South
Kensington, Exhibition Road, SW7 2AZ, UK. 2RAFT Institute of Plastic Surgery,
Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN, UK. 3UCL Institute
of Orthopaedics and Musculoskeletal Science, Royal National Orthopaedic
Hospital, Brockley Hill, Stanmore, HA7 4LP, UK.
Received: 3 March 2013 Revised: 20 August 2013
Accepted: 11 November 2013 Published: 15 November 2013
References
1. Dobzyniak M, Fehring TK, Odum S: Early failure in total hip arthroplasty.
Clin Orthop Relat Res 2006, 447:76–78.
2. Kotwal RS, Ganapathi M, John A, Maheson M, Jones SA: Outcome of
treatment for dislocation after primary total hip replacement. J Bone
Joint Surg Br 2009, 91:321–326.
3. Joshi A, Lee CM, Markovic L, Vlatis G, Murphy JC: Prognosis of dislocation
after total hip arthroplasty. J Arthroplasty 1998, 13:17–21.
4. Yim SJ, Kim MY, Suh YS: Impaction allograft with cement for the revision
of the femoral component. A minimum 39-month follow-up study with
the use of the Exeter stem in Asian hips. Int Orthop 2007, 31:297–302.
5. Howie DW, Callary SA, McGee MA, Russell NC, Solomon LB: Reduced
femoral component subsidence with improved impaction grafting at
revision hip arthroplasty. Clin Orthop Relat Res 2010, 468:3314–3321.
6. Ornstein E, Atroshi I, Franzen H, Johnsson R, Sandquist P, Sundberg M:
Results of hip revision using the Exeter stem, impacted allograft bone,
and cement. Clin Orthop Relat Res 2001, 389:126–133.
7. Franzen H, Mjoberg B, Onnerfalt R: Early loosening of femoral components
after cemented revision. A roentgen stereophotogrammetric study.
J Bone Joint Surg Br 1992, 74:721–724.
8. Franzen H, Toksvig-Larsen S, Lidgren L, Onnerfalt R: Early migration of femoral
components revised with impacted cancellous allografts and cement. A
preliminary report of five patients. J Bone Joint Surg Br 1995, 77:862–864.
9. Snorrason F, Karrholm J: Early loosening of revision hip arthroplasty. A
roentgen stereophotogrammetric analysis. J Arthroplasty 1990, 5:217–229.
10. Ornstein E, Franzen H, Johnsson R, Stefansdottir A, Sundberg M, Tagil M:
Five-year follow-up of socket movements and loosening after revision
with impacted morselized allograft bone and cement: a radiostereometric
and radiographic analysis. J Arthroplasty 2006, 21:975–984.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD,
Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential
of adult human mesenchymal stem cells. Science 1999, 284:143–147.
12. Rust PA, Kalsi P, Briggs TW, Cannon SR, Blunn GW: Will mesenchymal stem
cells differentiate into osteoblasts on allograft? Clin Orthop Relat Res 2007,
457:220–226.
13. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E,
Domenech J: Phenotypical and functional characteristics of
Reissis et al. Stem Cell Research & Therapy 2013, 4:139 Page 11 of 11
http://stemcellres.com/content/4/6/139mesenchymal stem cells from bone marrow: comparison of culture
using different media supplemented with human platelet lysate or fetal
bovine serum. Stem Cell Res Ther 2012, 3:6.
14. Pietila M, Lahteenmaki K, Lehtonen S, Leskela HV, Narhi M, Lonnroth M,
Matto J, Lehenkari P, Nordstrom K: Monitoring mitochondrial inner
membrane potential for detecting early changes in viability of
bacterium-infected human bone marrow-derived mesenchymal stem
cells. Stem Cell Res Ther 2012, 3:53.
15. Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM:
Osteogenic differentiation of mesenchymal stem cells is regulated by
osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater
2012, 3:13–27.
16. Zhou Y, Guan X, Zhu Z, Gao S, Zhang C, Li C, Zhou K, Hou W, Yu H:
Osteogenic differentiation of bone marrow-derived mesenchymal
stromal cells on bone-derived scaffolds: effect of microvibration and role
of ERK1/2 activation. Eur Cell Mater 2011, 22:12–25.
17. Korda M, Blunn G, Phipps K, Rust P, Di Silvio L, Coathup M, Goodship A, Hua
J: Can mesenchymal stem cells survive under normal impaction force in
revision total hip replacements? Tissue Eng 2006, 12:625–630.
18. Gill HS, Campbell PA, Murray DW, De Smet KA: Reduction of the potential for
thermal damage during hip resurfacing. J Bone Joint Surg Br 2007, 89:16–20.
19. Toksvig-Larsen S, Franzen H, Ryd L: Cement interface temperature in hip
arthroplasty. Acta Orthop Scand 1991, 62:102–105.
20. Reckling FW, Dillon WL: The bone–cement interface temperature during
total joint replacement. J Bone Joint Surg Am 1977, 59:80–82.
21. Stanczyk M, van Rietbergen B: Thermal analysis of bone cement polymerisation
at the cement–bone interface. J Biomech 2004, 37:1803–1810.
22. Leeson MC, Lippitt SB: Thermal aspects of the use of
polymethylmethacrylate in large metaphyseal defects in bone. A clinical
review and laboratory study. Clin Orthop Relat Res 1993, 295:239–245.
23. Hsieh PH, Shih CH, Chang YH, Lee MS, Yang WE, Shih HN: Treatment of
deep infection of the hip associated with massive bone loss: two-stage
revision with an antibiotic-loaded interim cement prosthesis followed by
reconstruction with allograft. J Bone Joint Surg Br 2005, 87:770–775.
24. DiMaio FR: The science of bone cement: a historical review. Orthopedics
2002, 25:1399–1407.
25. Xie C, Reynolds D, Awad H, Rubery PT, Pelled G, Gazit D, Guldberg RE,
Schwarz EM, O’Keefe RJ, Zhang X: Structural bone allograft combined with
genetically engineered mesenchymal stem cells as a novel platform for
bone tissue engineering. Tissue Eng 2007, 13:435–445.
26. Di Bella C, Aldini NN, Lucarelli E, Dozza B, Frisoni T, Martini L, Fini M, Donati
D: Osteogenic protein-1 associated with mesenchymal stem cells promote
bone allograft integration. Tissue Eng Part A 2010, 16:2967–2976.
27. Korda M, Blunn G, Goodship A, Hua J: Use of mesenchymal stem cells to
enhance bone formation around revision hip replacements. J Orthop Res
2008, 26:880–885.
28. Nociari MM, Shalev A, Benias P, Russo C: A novel one-step, highly sensitive
fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol
Methods 1998, 213:157–167.
29. Altman SA, Randers L, Rao G: Comparison of trypan blue dye exclusion
and fluorometric assays for mammalian cell viability determinations.
Biotechnol Prog 1993, 9:671–674.
30. Li S, Chien S, Branemark PI: Heat shock-induced necrosis and apoptosis in
osteoblasts. J Orthop Res 1999, 17:891–899.
31. Eriksson A, Albrektsson T, Grane B, McQueen D: Thermal injury to bone. A
vital-microscopic description of heat effects. Int J Oral Surg 1982, 11:115–121.
32. Reis RS, Neves I Jr, Lourenco SL, Fonseca LS, Lourenco MC: Comparison of
flow cytometric and Alamar Blue tests with the proportional method for
testing susceptibility of Mycobacterium tuberculosis to rifampin and
isoniazid. J Clin Microbiol 2004, 42:2247–2248.
33. Lavenus S, Berreur M, Trichet V, Pilet P, Louarn G, Layrolle P: Adhesion and
osteogenic differentiation of human mesenchymal stem cells on
titanium nanopores. Eur Cell Mater 2011, 22:84–96.
doi:10.1186/scrt350
Cite this article as: Reissis et al.: The effect of temperature on the
viability of human mesenchymal stem cells. Stem Cell Research & Therapy
2013 4:139.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
